Your session is about to expire
← Back to Search
Radiation
Radiotherapy for Early Stage Breast Cancer (IORT Trial)
N/A
Waitlist Available
Led By Peter V Chen, MD
Research Sponsored by Hoag Memorial Hospital Presbyterian
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 years
Awards & highlights
IORT Trial Summary
This trial will test whether using MRI in addition to mammography and ultrasound can help doctors better determine how much cancer there is in the breast.
Eligible Conditions
- Breast Cancer
IORT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of Participants Receiving Additional Surgery Because of Positive or Close Margins as a Measure of the Accuracy of Pre-Operative Assessment
Secondary outcome measures
Cosmesis Scores by Physician and Self-Assessment
Progression Free Survival in the First Five Years
Proportion of Participants Recommended to Have Additional Whole Breast Radiation Therapy (WBRT) Because of High Risk Features Found on Final Pathology as a Measure of the Accuracy of Pre-Operative Assessment
+2 moreIORT Trial Design
1Treatment groups
Experimental Treatment
Group I: IORTExperimental Treatment1 Intervention
Treated with Intraoperative Radiation Therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intraoperative Radiotherapy
2012
N/A
~250
Find a Location
Who is running the clinical trial?
Hoag Memorial Hospital PresbyterianLead Sponsor
34 Previous Clinical Trials
14,495 Total Patients Enrolled
2 Trials studying Breast Cancer
148 Patients Enrolled for Breast Cancer
Peter V Chen, MDPrincipal InvestigatorHoag Memorial Hospital Presbyterian
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have severe mental or addictive disorders that could interfere with your participation in the study.You are currently receiving hormone or chemotherapy as your first treatment to shrink the tumor.
Research Study Groups:
This trial has the following groups:- Group 1: IORT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for participants to join this experiment?
"The clinicaltrials.gov website states that this specific trial is no longer recruiting participants; the first post was made on June 1st 2010 and the last edit occurred on August 1st 2022. However, out of 2602 other trials currently in operation across numerous locations, there are plenty of opportunities to take part in a medical study right now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger